eFFECTOR Therapeutics, Inc. EFTR
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $200.0K
- P/E
- 0.0×
Follow EFTR
| Older periods | Jun '23 | Sep '23 | Dec '23 | Mar '24 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.05 | 0.75 | 0.71 | 0.99 | |
Current Ratio |
1.09 | 0.82 | 0.77 | 1.03 | |
Net Debt/EBITDA |
0.73 | (0.19) | (0.12) | 0.77 | |
Debt/Assets |
71.56% | 95.75% | 94.36% | 69.72% | |
Debt/Equity |
7.47 | (4.87) | (3.35) | 22.87 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.03 | 0.93 | 0.61 | 0.82 | |
Capex/Depreciation |
0.55 | 0.01 | 0.76 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.49) | (3.14) | (2.54) | (1.78) | |
Capex per Share |
(0.01) | 0.00 | (0.02) | 0.00 | |
Free Cash Flow per Share |
(4.51) | (3.14) | (2.57) | (1.78) | |
Cash per Share |
13.08 | 7.20 | 8.40 | 6.22 | |
Shareholders Equity per Share |
1.35 | (1.61) | (2.65) | 0.20 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.35 | (1.61) | (2.65) | 0.20 | |
Free Cash Flow |
(8.62) | (7.76) | (5.62) | (7.28) | |
Working Capital |
2.22 | (4.31) | (5.96) | 0.68 | |
Capital Expenditures |
(0.03) | 0.00 | (0.05) | — | |
Net Current Asset Value |
1.66 | (4.84) | (6.50) | (0.05) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.14 | 0.06 | — | — | |
Average Payables |
1.33 | 1.18 | 1.91 | 2.75 | |
Average Assets |
35.18 | 28.41 | 24.81 | 24.53 | |
Average Common Equity |
11.10 | 3.80 | (0.95) | (1.99) |
Columns are period end dates